QNCX Annual CFI
-$5.76 M
-$23.76 M-131.99%
31 December 2023
Summary:
As of January 23, 2025, QNCX annual cash flow from investing activities is -$5.76 million, with the most recent change of -$23.76 million (-131.99%) on December 31, 2023. During the last 3 years, it has risen by +$46.67 million (+89.02%). QNCX annual CFI is now -109.77% below its all-time high of $58.95 million, reached on December 31, 2021.QNCX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX Quarterly CFI
$7.11 M
+$12.08 M+242.73%
30 September 2024
Summary:
As of January 23, 2025, QNCX quarterly cash flow from investing activities is $7.11 million, with the most recent change of +$12.08 million (+242.73%) on September 30, 2024. Over the past year, it has increased by +$1.72 million (+31.82%). QNCX quarterly CFI is now -77.55% below its all-time high of $31.64 million, reached on March 31, 2021.QNCX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX TTM CFI
$16.43 M
+$3.47 M+26.77%
30 September 2024
Summary:
As of January 23, 2025, QNCX TTM cash flow from investing activities is $16.43 million, with the most recent change of +$3.47 million (+26.77%) on September 30, 2024. Over the past year, it has increased by +$22.19 million (+385.36%). QNCX TTM CFI is now -74.11% below its all-time high of $63.46 million, reached on June 30, 2021.QNCX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -132.0% | +31.8% | +385.4% |
| 3 y3 years | +89.0% | +31.8% | +385.4% |
| 5 y5 years | +87.7% | +31.8% | +385.4% |
QNCX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -109.8% | at low | -66.0% | +135.0% | -72.1% | +385.4% |
| 5 y | 5-year | -109.8% | +89.0% | -77.5% | +109.8% | -74.1% | +117.6% |
| alltime | all time | -109.8% | +89.0% | -77.5% | +109.8% | -74.1% | +117.6% |
Quince Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.11 M(-242.7%) | $16.43 M(+26.8%) |
| June 2024 | - | -$4.98 M(-155.8%) | $12.96 M(-643.7%) |
| Mar 2024 | - | $8.91 M(+65.4%) | -$2.38 M(-58.6%) |
| Dec 2023 | -$5.76 M(-132.0%) | $5.39 M(+48.3%) | -$5.76 M(-176.6%) |
| Sept 2023 | - | $3.63 M(-117.9%) | $7.52 M(-252.1%) |
| June 2023 | - | -$20.32 M(-466.8%) | -$4.94 M(-148.8%) |
| Mar 2023 | - | $5.54 M(-70.3%) | $10.13 M(-43.7%) |
| Dec 2022 | $18.00 M(-69.5%) | $18.67 M(-311.5%) | $18.00 M(-11.1%) |
| Sept 2022 | - | -$8.83 M(+68.1%) | $20.25 M(-32.1%) |
| June 2022 | - | -$5.25 M(-139.1%) | $29.85 M(-26.7%) |
| Mar 2022 | - | $13.41 M(-35.9%) | $40.72 M(-30.9%) |
| Dec 2021 | $58.95 M | $20.92 M(+2630.9%) | $58.95 M(+9.5%) |
| Sept 2021 | - | $766.00 K(-86.4%) | $53.86 M(-15.1%) |
| June 2021 | - | $5.62 M(-82.2%) | $63.46 M(+22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $31.64 M(+99.9%) | $51.89 M(-199.0%) |
| Dec 2020 | -$52.43 M(+195.4%) | $15.83 M(+52.6%) | -$52.43 M(+3.7%) |
| Sept 2020 | - | $10.37 M(-274.4%) | -$50.55 M(-2.2%) |
| June 2020 | - | -$5.95 M(-91.8%) | -$51.70 M(-44.8%) |
| Mar 2020 | - | -$72.68 M(-510.5%) | -$93.59 M(+427.4%) |
| Dec 2019 | -$17.75 M(-62.0%) | $17.70 M(+92.0%) | -$17.75 M(-47.6%) |
| Sept 2019 | - | $9.22 M(-119.3%) | -$33.89 M(-62.9%) |
| June 2019 | - | -$47.84 M(-1611.9%) | -$91.41 M(+109.7%) |
| Mar 2019 | - | $3.16 M(+102.7%) | -$43.59 M(-6.8%) |
| Dec 2018 | -$46.75 M(>+9900.0%) | $1.56 M(-103.2%) | -$46.75 M(-3.2%) |
| Sept 2018 | - | -$48.30 M(>+9900.0%) | -$48.31 M(>+9900.0%) |
| June 2018 | - | -$14.00 K(<-9900.0%) | -$14.00 K(<-9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | -$77.00 K | - | - |
FAQ
- What is Quince Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Quince Therapeutics?
- What is Quince Therapeutics annual CFI year-on-year change?
- What is Quince Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Quince Therapeutics?
- What is Quince Therapeutics quarterly CFI year-on-year change?
- What is Quince Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Quince Therapeutics?
- What is Quince Therapeutics TTM CFI year-on-year change?
What is Quince Therapeutics annual cash flow from investing activities?
The current annual CFI of QNCX is -$5.76 M
What is the all time high annual CFI for Quince Therapeutics?
Quince Therapeutics all-time high annual cash flow from investing activities is $58.95 M
What is Quince Therapeutics annual CFI year-on-year change?
Over the past year, QNCX annual cash flow from investing activities has changed by -$23.76 M (-131.99%)
What is Quince Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of QNCX is $7.11 M
What is the all time high quarterly CFI for Quince Therapeutics?
Quince Therapeutics all-time high quarterly cash flow from investing activities is $31.64 M
What is Quince Therapeutics quarterly CFI year-on-year change?
Over the past year, QNCX quarterly cash flow from investing activities has changed by +$1.72 M (+31.82%)
What is Quince Therapeutics TTM cash flow from investing activities?
The current TTM CFI of QNCX is $16.43 M
What is the all time high TTM CFI for Quince Therapeutics?
Quince Therapeutics all-time high TTM cash flow from investing activities is $63.46 M
What is Quince Therapeutics TTM CFI year-on-year change?
Over the past year, QNCX TTM cash flow from investing activities has changed by +$22.19 M (+385.36%)